Genome-scale analysis identifies NEK2, DLGAP5 and ECT2 as promising diagnostic and prognostic biomarkers in human lung cancer

por Yuan-Xiang Shi, Ji-Ye Yin, Yao Shen, Wei Zhang, Hong-Hao Zhou, Zhao-Qian Liu
Publicado 2017

Gene-gene and gene-environment interactions influence platinum-based chemotherapy response and toxicity in non-small cell lung cancer patients

por Jia-Jia Cui, Lei-Yun Wang, Tao Zhu, Wei-Jing Gong, Hong-Hao Zhou, Zhao-Qian Liu, Ji-Ye Yin
Publicado 2017

Genetic Polymorphisms and Platinum-based Chemotherapy Treatment Outcomes in Patients with Non-Small Cell Lung Cancer: A Genetic Epidemiology Study Based Meta-analysis

por Li-Ming Tan, Cheng-Feng Qiu, Tao Zhu, Yuan-Xiang Jin, Xi Li, Ji-Ye Yin, Wei Zhang, Hong-Hao Zhou, Zhao-Qian Liu
Publicado 2017

Author Correction: MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway

por Chao Fang, Yi-Xin Chen, Na-Yiyuan Wu, Ji-Ye Yin, Xiang-Ping Li, Hsuan-Shun Huang, Wei Zhang, Hong-Hao Zhou, Zhao-Qian Liu
Publicado 2021

Analytics of the clinical implementation of pharmacogenomics testing in 12 758 individuals

por Yang Wang, Fan Xiao, Yan Chen, Le‐Dong Xiao, Lei‐Yun Wang, Yan Zhan, Xing‐Liang Xiong, Gang Zhou, Rong Liu, Dong‐Sheng Ouyang, Zhi Li, Howard L McLeod, Wei Zhang, Qing Li, Zhao‐Qian Liu, Hong‐Hao Zhou, Ji‐Ye Yin
Publicado 2021